Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor

Scandinavian Journal of Immunology

Volumn 49, Issue 5, 1999, Pages 495-500

  Welker, P ^a   Grabbe, J ^b   Gibbs, B ^b   Zuberbier, T ^a   Henz, B M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; IMMUNOGLOBULIN E ANTIBODY; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; STEM CELL FACTOR;

ARTICLE; AUTOCRINE EFFECT; BASOPHIL; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; LANGERHANS CELL; MAST CELL; MASTOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD;

CELL LINE; CELL MEMBRANE; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; MAST CELLS; PROTEIN ISOFORMS; SKIN; SOLUBILITY; STAINING AND LABELING; STEM CELL FACTOR; TUMOR CELLS, CULTURED;

EID: 0032977542     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00519.x     Document Type: Article

References (26)

1. Grabbe J, Welker P, Dippel E, Czarnetzki BM. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994;287:78-84.
2. Langley KE, Mendiaz EA, Liu N et al. Properties of variant forms of human stem cell factor recombinantly expressed in E. coli. Arch Biochem Biophys 1994;194:55-61.
3. Longley BJ, Tyrrell L, Ma Y et al. Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA 1997;94:9017-21.
4. Flanagan JG, Chan DC, Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 1991;64:1025-35.
5. Longley BJ Jr, Morganroth GS, Tyrrell L et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993;328:1302-7.
6. Hamann K, Haas N, Grabbe J, Czarnetzki BM. Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol 1995; 133:203-8.
7. Grabbe J, Welker P, Rosenbach T et al. Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. J Invest Dermatol 1996; 107:219-24.
8. Patella V, de Crescenzo G, Lamparter-Schummert B, De Rosa G, Adt M, Marone G. Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy. Inflamm Res 1997;46 (Suppl. 1):31-2.
9. Patella V, Marino I, Arbustini E et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998;97:971-8.
10. Christofidou-Solomidou M, Longley BJ, Whitaker-Menezes D, Albelda SM, Murphy GF. Human skin/SCID mouse chimeras as an in vivo model for human cutaneous mast cell hyperplasia. J Invest Dermatol 1997;109:102-7.
11. Grabbe J, Welker P, Möller A, Dippel E, Ashman LF, Czarnnetzki BM. Comparative cytokine release from human mononcytes, monocyte-derived immature mast cells and a human mast cell line (HMC1). J Invest Dermatol 1994;103:504-8.
12. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Res 1988;12:345-55.
13. Kishi K. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 1985;9:381-90.
14. Krüger-Krasagakes S, Möller AM, Kolde G, Lippert U, Weber S, Henz BM. Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 1996;106:75-9.
15. Hamann K, Grabbe J, Welker P, Haas N, Algermissen B, Czarnetzki BM. Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res 1994;286:380-5.
16. Tsao MC, Ham RG. Clonal growth of normal human epidermal keratinocytes in a defined medium. J Cell Physiol 1992;89:7350-4.
17. Riske F, Hakimi J, Mallamaci M. High affinity human IgE receptor (FcεRI). Analysis of functional domains of the α-subunit with monoclonal antibodies. J Biol Chem 1991;266:11245-51.
18. Tokunaga K, Nakamura Y, Sakata K, Fujimori F, Ohkubo M, Sawada K, Sakiyama S. Enhanced expression of glyceraldehyd-3-phosphate. Cancer Res 1987;47:5616-19.
19. Furitsu T, Tsujujima T, Ikeda H et al. Identification of mutations in the coding sequence of the protooncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993;99:1736-44.
20. Henz BM. SCF and c-kit in mastocytosis - a pandora's box holding more theories than proven facts. J Invest Dermatol 1998;110:186.
21. Longley BJ. SCF and c-kit in mastocytosis - a Pandora's box holding more theories than proven facts. Reply. J Invest Dermatol 1998;110:186-7.
22. Möller A, Lippert U, Leßmann D et al. Human mast cells produce IL-8. J Immunol 1993;151:3261-6.
23. Möller A, Henz BM, Grützkau A et al. Comparative cytokine gene expression, regulation and release by human mast cells. Immunology 1998;93:289-95.
24. Ratajczak MZ, Luger SM, De Riel K, Abraham J, Calabretta B, Gewirtz AM. Role of the KIT proto-oncogene in normal and malignant human hematopoiesis. Proc Natl Acad Sci USA 1992;89:1710-18.
25. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994;153:3717-25.
26. Metcalfe DD, Mekori JA, Rottern M. Mast cell ontogeny and apoptosis. Exp Dermatol 1995;4:227-30.